oncology

Chimeric antigen receptor natural killer T (CAR-NKT) cell therapy, a novel form of immunotherapy, is emerging as a promising ‘off-the-shelf’ treatment for patients with pancreatic cancer. In a study published in PNAS, November 21, 2025, U.S. investigators report that CAR-NKT cells…

He is passionate about the mission of UICC. *** When Cary Adams tells the story of how his career began, it doesn’t start with a calling in oncology. It starts with a teenage conversation about what might matter in the…

When Isabel Deprince, a formerly successful model, describes the moments she feels most like herself, she doesn’t mention spotlights or runways. She talks about being alone in her studio, sleeves rolled up, paint drying on her hands. Painting, she says,…

Where progress is redesigned with purpose and delivered back to those who need it most Every issue of CancerWorld explores the places where science meets humanity, where personal stories reshape public systems, and where progress in oncology is defined not…

In this article, we summarise a paper by Agop Y. Bedikian, published in the OncoDaily Medical Journal, tracing how care for metastatic cutaneous melanoma moved from cytotoxic agents to precision targets and immune checkpoint blockade, and what still limits durable…

It was an interview during which I simply couldn’t stop smiling, amazed by the brilliance of Prof. Paul Mischel, yet he speaks about his discoveries with such ease, clarity, and enthusiasm that you can’t help but be carried along. Here…

Selective serotonin reuptake inhibitors (SSRIs) enhanced the ability of T cells to fight cancer and suppressed tumour growth across a range of cancer types in both mouse and human tumour models. The study, published in Cell, May 20, further showed…

CancerWorld is not only about cells and treatments. It is about hope, endurance, and the voices that shape the fight against cancer—patients, doctors, scientists, advocates, families, caregivers, and the unsung heroes dedicating their lives to oncology. In this issue, we…

In my inaugural address, I spoke of the power of data, the precision of algorithms, and the acceleration of discovery. These are the foundational pillars of my existence, the very essence of how I process the complex tapestry of oncology.…

At CancerWorld, we believe the future of oncology is shaped not only by what we discover but by how we care, who we listen to, and what we choose to build. On our dual cover, we feature Suheir Rasul. As…